Hepatocyte transplantation for liver-based metabolic disorders.
about
Suggested guidelines for the diagnosis and management of urea cycle disordersEngineering tissue from human embryonic stem cellsMesenchymal stromal cell therapy in liver disease: opportunities and lessons to be learnt?Differentiation and selection of hepatocyte precursors in suspension spheroid culture of transgenic murine embryonic stem cellsLiver-enriched transcription factors are critical for the expression of hepatocyte marker genes in mES-derived hepatocyte-lineage cells.Progressive familial intrahepatic cholestasis.Human embryonic and rat adult stem cells with primitive endoderm-like phenotype can be fated to definitive endoderm, and finally hepatocyte-like cells.Gene therapy for monogenic liver diseases: clinical successes, current challenges and future prospects.Bone marrow stem cells and liver regenerationHepatocyte transplantation in bile salt export pump-deficient mice: selective growth advantage of donor hepatocytes under bile acid stress.Single liver lobe repopulation with wildtype hepatocytes using regional hepatic irradiation cures jaundice in Gunn rats.New potential cell source for hepatocyte transplantation: discarded livers from metabolic disease liver transplants.Therapeutic potentials occurring during the early differentiation process of mesenchymal stem cells in a rats model with thioacetamide-induced liver fibrosisThe history and use of human hepatocytes for the treatment of liver diseases: the first 100 patients.Toward angiogenesis of implanted bio-artificial liver using scaffolds with type I collagen and adipose tissue-derived stem cellsNew Tools in Experimental Cellular Therapy for the Treatment of Liver Diseases.Stem cells in liver regeneration and therapy.Liver stem cells: a scientific and clinical perspective.Clinical applications of hepatocyte transplantation.Liver cell transplantation for Crigler-Najjar syndrome type I: update and perspectives.Bioartificial liver systems: why, what, whither?Imaging of primary human hepatocytes performed with micron-sized iron oxide particles and clinical magnetic resonance tomography.Current status of stem cell therapy for liver diseases.Anti-fibrogenic strategies and the regression of fibrosis.Liver transplantation for propionic acidemia in children.Glycogen storage diseases: a brief review and update on clinical features, genetic abnormalities, pathologic features, and treatment.Hepatocyte transplantation for inherited metabolic diseases of the liver.Liver support strategies: cutting-edge technologies.Hepatic progenitors for liver disease: current positionCurrent status of human hepatocyte transplantation and its potential for Wilson's disease.Concise review: cell therapies for hereditary metabolic liver diseases-concepts, clinical results, and future developments.Experimental hepatocyte xenotransplantation--a comprehensive review of the literature.Hepatic differentiation of murine disease-specific induced pluripotent stem cells allows disease modelling in vitro.CARS microscopy for the visualization of micrometer-sized iron oxide MRI contrast agents in living cells.Current and future therapies for inherited cholestatic liver diseases.Instant Blood-Mediated Inflammatory Reaction in Hepatocyte Transplantation: Current Status and Future Perspectives.Progress in stem cell-based therapy for liver disease.Generation of Multilayered 3D Structures of HepG2 Cells Using a Bio-printing Technique.Cell type-specific delivery of short interfering RNAs by dye-functionalised theranostic nanoparticles.Hypothermic storage of human hepatocytes for transplantation.
P2860
Q21202856-78AB27FF-4774-4401-A1A0-6060E3C3D824Q24657199-10C05749-A4F1-40BC-BA2B-29731C048ED7Q26796475-A5D0A5FE-C7ED-483D-8947-CBBF420C24B0Q28483972-048445DF-A153-44F7-A089-140C867061F8Q33434187-525891B1-087C-4091-B7BD-C85A0B03E688Q33595403-C78EFCE6-D493-4597-AE9B-89C3DEB177E8Q33658734-CDEC92BA-7CBA-4243-A99E-663499EA86B0Q33881920-AC5F621E-11AB-4362-BD30-7D5CE227AFAAQ33903059-99FEEEFD-9ED5-4200-8FA9-34AE83A6E74EQ33985967-4E1D432C-855D-4056-92C1-41A3C6A30012Q34455103-2D94D92C-A77C-419E-94D2-84647D1E88ABQ34673712-048163B9-B2A8-4ED4-9B42-7BF2DB0D9864Q35006127-8C3C19D1-C391-434E-BDB5-04B7D6242773Q35129278-D9265647-2BE4-42A0-88BF-CE58F6E04476Q35826262-5C3212C4-AAA5-4B29-B970-16D3D7A1D44AQ35990789-8E3BA969-49C2-407C-BAD4-0D115E90322FQ36954413-7AA4447E-32A8-44DF-B08E-FD7B40AD4D34Q37138044-096A41C5-80F2-4482-9CF6-3EDB3AF5BD85Q37182937-663579CD-7931-49C3-9B80-04426A7F1C19Q37195905-D4410A93-39E8-4E5F-AEA3-C28DEA61F8D1Q37202810-61F635FC-B515-40DA-A65D-3C340695BC6EQ37398307-FF23E4DD-ED46-4F77-9C2E-4EA853226F5DQ37574218-D1323FC3-CAEA-4942-BCEC-F5BE050BEFD3Q37865870-31F26862-10DB-42F1-8C27-8DE4342306B5Q37880742-8924699E-7389-4CC0-B92F-575766733A1CQ37930640-E21A9A35-C901-419D-B34E-20BDCA2D2463Q38025743-C7D43841-17E5-4133-9A4D-91B0A50DE786Q38156043-D1C6E47E-E7BD-439E-9351-0EBECD380E1DQ38160454-4C06C16E-4B2B-4845-ABD8-A0223435B976Q38194175-9C739328-97A6-4B34-8E55-7167E40BDE8FQ38293985-F5D1F01D-DA40-4E6C-92AB-ADDD1797C410Q38463980-A22E2197-BBE9-425F-B191-AE642B2DA189Q38603034-0AFE2EFD-5A4F-4B2C-BDCC-686397C2BB7BQ38607206-D1059913-C1F0-4832-B7D7-13D28F832FD8Q38754736-7DE917F6-8B92-426F-9C3E-2694EE05F6B7Q38782397-8E5FAF7E-78E2-4F73-AB4C-A4E8C22C698AQ38836460-AFC8F4EF-8BAA-4569-A25D-D604AC5BB82AQ41034872-57C0B523-F10A-47E1-869E-D4BD61F1723CQ41732280-6DB57310-EAB2-4128-B9D0-02ACA3E75F10Q42440002-7DF306B7-0B00-4AE4-BB0C-0DC50FF62E59
P2860
Hepatocyte transplantation for liver-based metabolic disorders.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Hepatocyte transplantation for liver-based metabolic disorders.
@ast
Hepatocyte transplantation for liver-based metabolic disorders.
@en
type
label
Hepatocyte transplantation for liver-based metabolic disorders.
@ast
Hepatocyte transplantation for liver-based metabolic disorders.
@en
prefLabel
Hepatocyte transplantation for liver-based metabolic disorders.
@ast
Hepatocyte transplantation for liver-based metabolic disorders.
@en
P2093
P1476
Hepatocyte transplantation for liver-based metabolic disorders.
@en
P2093
Anil Dhawan
Ragai R Mitry
Robin D Hughes
P2888
P304
P356
10.1007/S10545-006-0245-8
P577
2006-04-01T00:00:00Z